TORONTO – Triumf Innovations Inc., the business arm of Canada's national particle accelerator center, and Vancouver, British Columbia's Center for Drug Research and Development (CDRD) have joined forces in a worldwide "renaissance" using targeted alpha-particle therapy to fight cancer.